Akèy › Menenjyom › Massachusetts
Etid klinik pou Menenjyom nan Massachusetts
6 etid pou Menenjyom ap chèche patisipan nan sit nan Massachusetts.
Vil nan Massachusetts
Tèks ofisyèl etid la (Anglè)
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
- Massachusetts General Hospital Cancer Center, Boston
- Dana-Farber Cancer Institute, Boston
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT02523014Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment
- Dana-Farber/Harvard Cancer Center, Boston
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06955169A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
- Massachusetts General Hospital, Boston
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT07428616Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)
- Massachusetts General Hospital, Boston
Ap rekriteFaz 2
Laj 12 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT04374305A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma
- Mass General, Boston
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 30, 2026 · NCT07533942Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
- Beth Israel Deaconess Medical Center, Boston
- Beth Israel Deaconess Medical Center, Boston
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Jul 22, 2026 · NCT04427384Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.